UBS Group’s Maxim Integrated Products MXIM Stock Holding History

UBS Group’s Portfolio MXIM Stock Details MXIM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-50,000	Closed	-$1.9M	–	8403
2015 Q4	$1.9M	Buy	+50,000	New	+$1.91M	﹤0.01%	2840
2015 Q3	–	Sell	-25,300	Closed	-$875K	–	8756
2015 Q2	$875K	Buy	25,300 +24,600	+3,514%	+$841K	﹤0.01%	3676
2015 Q1	$24K	Buy	700 +100	+17%	+$3.41K	﹤0.01%	6810
2014 Q4	$19K	Buy	+600	New	+$17.6K	﹤0.01%	7757

Other funds holding MXIM

CCM

Coldstream Capital Management Bellevue, Washington $8.12B AUM 17.95% 1-Year Est. Return

Rowlandmiller & Partners Atlanta, Georgia $549M AUM 36.2% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

UBS Group's MXIM Position: Q3 2021 in Review

UBS Group sold out of Maxim Integrated Products (MXIM) in Q3 2021, closing a stake of 377,796 shares — an estimated $39.8M sold.

UBS Group first reported a position in MXIM in Q4 2014 and held it in 27 quarters. The position peaked at $63.5M in Q4 2020. 3 funds tracked by Wall St. Rank hold MXIM as of Q3 2021.

UBS Group reported no remaining Maxim Integrated Products position as of Q3 2021 after selling out during the quarter.
UBS Group sold 377,796 Maxim Integrated Products shares in Q3 2021, an estimated $39.8M.
UBS Group first reported a position in Maxim Integrated Products in Q4 2014 and held it in 27 quarters.
UBS Group's Maxim Integrated Products position peaked at $63.5M in Q4 2020.
3 funds tracked by Wall St. Rank held Maxim Integrated Products as of Q3 2021.

Based on UBS Group's 13F filing for Q3 2021, filed 15 Nov 2021.